S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

The Biotech Growth Trust Share Forecast, Price & News

Today's Range N/A
50-Day Range
52-Week Range N/A
Volume127,182 shs
Average Volume99,827 shs
Market Capitalization£488.64 million
P/E Ratio2.36
Dividend YieldN/A

Receive BIOG News and Ratings via Email

Sign-up to receive the latest news and ratings for The Biotech Growth Trust and its competitors with MarketBeat's FREE daily newsletter.

The Biotech Growth Trust logo

About The Biotech Growth Trust

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Asset Management
Year Founded

Sales & Book Value

Annual Sales
£222.11 million
Book Value
GBX 1,446.40 per share





Market Cap
£488.64 million
Next Earnings Date
11/11/2021 (Estimated)
Not Optionable


Overall MarketRank

1.10 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

The Biotech Growth Trust (LON:BIOG) Frequently Asked Questions

What stocks does MarketBeat like better than The Biotech Growth Trust?

Wall Street analysts have given The Biotech Growth Trust a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but The Biotech Growth Trust wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is The Biotech Growth Trust's next earnings date?

The Biotech Growth Trust is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for The Biotech Growth Trust

Who are The Biotech Growth Trust's key executives?

The Biotech Growth Trust's management team includes the following people:
  • Mr. Samuel David Isaly, Portfolio Mang. (Age 76)

What other stocks do shareholders of The Biotech Growth Trust own?

What is The Biotech Growth Trust's stock symbol?

The Biotech Growth Trust trades on the London Stock Exchange (LON) under the ticker symbol "BIOG."

How do I buy shares of The Biotech Growth Trust?

Shares of BIOG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How much money does The Biotech Growth Trust make?

The Biotech Growth Trust has a market capitalization of £0.00 and generates £222.11 million in revenue each year.

What is The Biotech Growth Trust's official website?

The official website for The Biotech Growth Trust is www.biotechgt.com.

Where are The Biotech Growth Trust's headquarters?

The Biotech Growth Trust is headquartered at 25 Southampton Buildings, LONDON, WC2A 1AL, United Kingdom.

How can I contact The Biotech Growth Trust?

The Biotech Growth Trust's mailing address is 25 Southampton Buildings, LONDON, WC2A 1AL, United Kingdom. The company can be reached via phone at +44-20-74264000.

This page was last updated on 10/17/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected]at.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.